The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
Open accessAbstract
OBJECTIVES: To investigate the performance of classic risk factors, and of some new biomarkers, in predicting cardiovascular mortality in very old people from the general population with no history of cardiovascular disease. DESIGN: The Leiden 85-plus Study (1997-2004) is an observational prospective cohort study with 5 years of follow-up. SETTING: General population of the city of Leiden, the Netherlands. PARTICIPANTS: Population based sample of participants aged 85 years (215 women and 87 men) with no history of cardiovascular disease; no other exclusion criteria. Main measurements Cause specific mortality was registered during follow-up. All classic risk factors included in the Framingham risk score (sex, systolic blood pressure, total and high density lipoprotein cholesterol, diabetes mellitus, smoking and electrocardiogram based left ventricular hypertrophy), as well as plasma concentrations of the new biomarkers homocysteine, folic acid, C reactive protein, and interleukin 6, were assessed at baseline. RESULTS: During follow-up, 108 of the 302 participants died; 32% (35/108) of deaths were from cardiovascular causes. Classic risk factors did not predict cardiovascular mortality when used in the Framingham risk score (area under receiver operating characteristic curve 0.53, 95% confidence interval 0.42 to 0.63) or in a newly calibrated model (0.53, 0.43 to 0.64). Of the new biomarkers studied, homocysteine had most predictive power (0.65, 0.55 to 0.75). Entering any additional risk factor or combination of factors into the homocysteine prediction model did not increase its discriminative power. CONCLUSIONS: In very old people from the general population with no history of cardiovascular disease, concentrations of homocysteine alone can accurately identify those at high risk of cardiovascular mortality, whereas classic risk factors included in the Framingham risk score do not. These preliminary findings warrant validation in a separate cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The elevation of homocysteine concentration in the blood has been reported to be a risk factor not just for CAD but also for stroke and PAD287–289).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [289]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · BMJ · doi:10.1136/bmj.39335.541782.ad · Cited by 10,766
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,708
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Self-citationRosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Flagged first, then by citations
Research works printed but not linked: 1
- Sattar N, Murray H, Blauw G, Bollen E, Buckley B, Cobbe S, et al. CRP and risk of vascular events in PROSPER. Circulation 2006;114:143.
Cited by
Sorted by citations
Items 201–300 of 339
Han, T.-W., Zhou, S., Li, J., Tian, F., Mu, Y., Jing, J., Han, Y., & Chen, Y. (2016) · PubMed Central · doi:10.11909/j.issn.1671-5411.2016.04.010 · Cited by 11
Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population
Padrela, B. E., Lorenzini, L., Collij, L. E., García, D. V., Coomans, E. M., Ingala, S., Tomassen, J., Deckers, Q., Shekari, M., de Geus, E. J. C., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231178993 · Cited by 9
Brunner, E. J., Shipley, M. J., Marmot, M. G., Mika Kivimaki, B., & Witte, D. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02921.x · Cited by 9
Córdova, C., Boullosa, D. A., Custódio, M. R. M., Quaglia, L. A., dos Santos, S. N., de Freitas, W. M., Sposito, A. C., & Nóbrega, O. D. T. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv216 · Cited by 9
Sisa, I. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.07.021 · Cited by 9
Trevisan, C., Capodaglio, G., Ferroni, E., Fedeli, U., Noale, M., Baggio, G., Manzato, E., Maggi, S., Corti, M. C., & Sergi, G. (2021) · European Journal of Ageing · doi:10.1007/s10433-021-00620-y · Cited by 9
Trends in the coronary heart disease risk profile of middle-aged adults
Kramarow, E. A., Lubitz, J. D., & Francis, R. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.10.004 · Cited by 9
Rizzo, L., Majnarić, L. T., & Longo, L. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-03840-3_15 · Cited by 9
Chen, B.-T., Tsai, P.-J., & Jiann, B.-P. (2024) · Sexual Medicine · doi:10.1093/sexmed/qfae089 · Cited by 7
Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score
Gariglio, L., Rivière, S., Morales, A., Porcile, R., Potenzoni, M. A., & Fridman, O. (2014) · Archivos de cardiología de México · doi:10.1016/j.acmx.2013.12.006 · Cited by 8
Lewis, T. J., Huang, J. H., & Trempe, C. L. (2020) · Cureus · doi:10.7759/cureus.10039 · Cited by 8
van Dijk, S. C., de Jongh, R. T., Enneman, A. W., Ham, A. C., Swart, K. M. A., van Wijngaarden, J. P., van der Zwaluw, N. L., Brouwer-Brolsma, E. M., van Schoor, N. M., Dhonukshe-Rutten, R. A. M., et al. (2015) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0650-x · Cited by 8
The importance of HDL-C and CRP in cardiovascular risk evaluation in longevous elderly individuals
Laks, R., Araújo, L. M. Q., Filho, C. D. M. A., & Cendoroglo, M. S. (2011) · Einstein (São Paulo) · doi:10.1590/s1679-45082011rw1953 · Cited by 8
Rahman, M. M. (2014) · Repository@Hull (Worktribe) (University of Hull) · Cited by 8
Cardiovascular Risk Prediction in Older Adults
Colantonio, L. D., & Bittner, V. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01339-2 · Cited by 9
Effect of exercise engagement and cardiovascular risk on neuronal injury
Stojanovic, M., Schindler, S. E., Morris, J. C., & Head, D. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13400 · Cited by 7
Reflections on the Importance of Frailty in the Assessment of Cardiovascular Risk in the Elderly
Formiga, F., Vidán, M. T., Ariza‐Solé, A., & Martínez‐Sellés, M. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.05.004 · Cited by 7
Kim, W. B., Park, J., & Kim, Y.-J. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.07.010 · Cited by 7
Adding multiple risk factors improves Framingham coronary heart disease risk scores
Root, M. M., Hu, G., & Duncan, A. W. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s69672 · Cited by 7
Poortvliet, R. K. E., van Peet, P. G., de Craen, A. J. M., Mertens, B. J., Mooijaart, S. P., Wijsman, L. W., Drewes, Y. M., Ford, I., Sattar, N. A., Jukema, J. W., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315617908 · Cited by 7
Self-citationLuo, J.-L., Chien, K., Hsu, H.-C., Su, T., Lin, H., Chen, P., Chen, M.-F., & Lee, Y. (2017) · Medicine · doi:10.1097/md.0000000000006716 · Cited by 7
Krabbe, C., Schipf, S., Ittermann, T., Dörr, M., Nauck, M. A., Chenot, J., Markus, M. R. P., & Völzke, H. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.016 · Cited by 7
Dimberg, L., Eriksson, B., & Hashem, M. (2019) · Public Health · doi:10.1016/j.puhe.2019.07.006 · Cited by 7
Rodríguez‐Sánchez, E., Navarro‐García, J. A., Aceves‐Ripoll, J., González‐Lafuente, L., Corbacho-Alonso, N., Martin, M. B., Madruga, F., Álvarez‐Llamas, G., Barderas, M. G., Ruilope, L. M., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab012 · Cited by 7
Cardiovascular Risk Prediction using JBS3 Tool: A Kerala based Study
Paul, P., George, N., & Shan, B. P. (2020) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405616666200103144559 · Cited by 9
What the Guidelines Do Not Say: Statin Non-benefit Groups
Morris, P. B., & McLain, K. H. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0468-3 · Cited by 7
Keegan, G. L., Bhardwaj, N., & Abdelhafiz, A. H. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2239907 · Cited by 6
Monsanto, H., Renta-Muñoz, A., Dones, W., Comulada, A., Cidre, C., & Orengo, J. C. (2014) · PubMed · Cited by 6
B-vitamin levels and genetics of hyperhomocysteinemia are not associated with arterial stiffness
van Dijk, S. C., Enneman, A. W., van Meurs, J., Swart, K. M. A., Ham, A. H., van Wijngaarden, J. P., Brouwer-Brolsma, E. M., van der Zwaluw, N. L., van Schoor, N. M., Dhonukshe-Rutten, R. A. M., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.008 · Cited by 6
Goto, M. (2012) · BioScience Trends · doi:10.5582/bst.2012.v6.1.33 · Cited by 6
Empirical evaluation of sub-cohort sampling designs for risk prediction modeling
Lee, M., Zeleniuch‐Jacquotte, A., & Liu, M. (2020) · Journal of Applied Statistics · doi:10.1080/02664763.2020.1861225 · Cited by 6
Łukaszyk, E., Bień‐Barkowska, K., & Bień, B. (2021) · Nutrients · doi:10.3390/nu13041098 · Cited by 7
Trovato, G. M., Catalano, D., Ragusa, A., Martines, G. F., Tonzuso, A., Pirri, C., Buccheri, M. A., Nora, C. D., & Trovato, F. M. (2013) · Renal Failure · doi:10.3109/0886022x.2013.779895 · Cited by 6
A Score for the Prediction of Cardiovascular Events in the Hypertensive Aged
Nelson, M. R., Ramsay, E. N., Ryan, P. J., Willson, K. J., Tonkin, A. M., Wing, L. M. H., Simons, L. A., & Reid, C. M. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.192 · Cited by 6
Mortality Associated with Diabetes and Cardiovascular Disease in Older Women
Nanchen, D., Rodondi, N., Cornuz, J., Hillier, T. A., Ensrud, K. E., Cauley, J. A., & Bauer, D. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048818 · Cited by 6
Karwa, V., Wanjari, A., Kumar, S., Dhondge, R. H., Patil, R., & Kothari, M. (2024) · Cureus · doi:10.7759/cureus.66341 · Cited by 8
Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00008-2 · Cited by 6
Court, T., Čapková, N., Pająk, A., Tamošiūnas, A., Bobák, M., & Pikhart, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1228807 · Cited by 5
Lever, M., George, P. M., Atkinson, W., Elmslie, J. L., Slow, S., Molyneux, S. L., Troughton, R. W., Richards, M., FRAMPTON, C. M. A., & Chambers, S. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032460 · Cited by 5
Oxidized LDL , Gamma‐Glutamyltransferase and Adverse Outcomes in Older Adults
Spoto, B., Mattace-Raso, F. U. S., Sijbrands, E. J. G., D’Arrigo, G., Tripepi, G., Volpato, S., Bandinelli, S., Ferrucci, L., & Zoccali, C. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14566 · Cited by 5
Modified risk associations of lipoproteins and apolipoproteins by chronic low-grade inflammation
Onat, A., Kaya, A., & Ademoğlu, E. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1417839 · Cited by 5
Riesgo cardiovascular en la población anciana española. Escala de riesgo EPICARDIAN
Gabriel, R., Muñiz, J., Vega, S., Moral, I., Pérez-Castro, T. R., Salvanés, F. R., Suárez, C., Novella, B., & Brotons, C. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2021.05.001 · Cited by 5
Slama, D. B. B., Fekih‐Mrissa, N., Haggui, A., Nsiri, B., Haouala, H., & Gritli, N. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1836-z · Cited by 5
Turusheva, A. V., Kotovskaya, Y. V., Frolova, E. V., & Kiseleva, G. V. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-3-258-266 · Cited by 5
Lee, J., Rhee, S., Lee, S., & Yu, K. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s145339 · Cited by 5
Abdelhafiz, A. H. (2009) · Wiley eBooks · doi:10.1002/9780470744093.ch5 · Cited by 5
Ghaem, H., Zibaeenezhad, M. J., Sayadi, M., Khosravaniardakani, S., Parsa, N., & Razeghian‐Jahromi, I. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200332 · Cited by 4
Left Ventricular Mass as a Risk Factor in the Oldest Old
Bursztyn, M., Leibowitz, D. W., Stessman‐Lande, I., Jacobs, J. M., Ein‐Mor, E., & Stessman, J. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12594 · Cited by 4
Turusheva, A. V., Frolova, E. V., Vaes, B., Hegendörfer, E., & Degryse, J. (2017) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.03.004 · Cited by 4
Cardiovascular Risk Calculators and their Applicability to South Asians
Bansal, M., Ranjan, S., & Kasliwal, R. R. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816999201001204020 · Cited by 5
Shimizu, R., Torii, H., Yasuda, D., Hiraoka, Y., Furukawa, Y., Yoshimoto, A., Iwakura, T., Matsuoka, N., Tomii, K., Kohara, N., et al. (2016) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2016.06.006 · Cited by 4
Obeidat, O. S., Makhamreh, H., Al-Muhaisen, R., Obeidat, L. R., Kitana, F. I., Amarin, J. Z., Ebada, M. A., Murad, M. A., Alhameedi, T., Haj-Yasin, D., et al. (2021) · Heart Views · doi:10.4103/heartviews.heartviews_67_20 · Cited by 4
Hsueh, P.-Y. S., Zhu, X., Hsiao, M., Lee, S. Y. F., Deng, V., & Ramakrishnan, S. (2014) · World Wide Web · doi:10.1007/s11280-014-0304-2 · Cited by 4
Diabetes management in older people: a focus on cardiovascular risk reduction
McNicholas, E., & Abdelhafiz, A. H. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1246346 · Cited by 4
Imado, Y., Takahashi, M., Soma, Y., Aburaya, S., Nakatani, K., Hanai, T., Bamba, T., & Izumi, Y. (2026) · Mass Spectrometry · doi:10.5702/massspectrometry.a0188 · Cited by 3
Kwiatkowska, I., Olszak, J., Brożek, A., Blacha, A., Nowicki, M., Maćkowiak, K., Formanowicz, P., & Formanowicz, D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032237 · Cited by 4
Homocysteïnespiegel en cardiovasculair risico
Poortvliet, R. K. E., & Drewes, Y. M. (2015) · Huisarts en Wetenschap · doi:10.1007/s12445-015-0165-7 · Cited by 3
Teh, R., Kerse, N. M., Robinson, E. M., Doughty, R. N., & WHALLEY, G. A. (2012) · Australian Journal on Ageing · doi:10.1111/j.1741-6612.2012.00626.x · Cited by 3
Kang, J., Han, K., Hyung, J., Hong, G., & Yoo, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.749098 · Cited by 3
Jazayeri, M., Abdolsamadi, H., Foroozandeh, M., Razavi, Z., Soltanian, A. R., & Hajilooi, M. (2020) · Avicenna journal of dental research · doi:10.34172/ajdr.2020.25 · Cited by 3
Importância da validação dos modelos de risco cardiovascular nos cuidados de saúde primários
Médica Interna de Medicina Geral e Familiar. USF São Julião, A. L. O. E. O., Gouveia, M., Pimenta, I., & Pinto, D. (2018) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v34i3.12449 · Cited by 3
Yang, X., Zhang, M., Song, R., Liu, C., Huo, Y., & Qian, G. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12473 · Cited by 3
Nanna, M. G., Peterson, E. D., Chiswell, K., Overton, R. A., Nelson, A. J., Kong, D. F., & Návar, A. M. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.02.004 · Cited by 2
Cardiovascular risk in the elderly population of Spain. The EPICARDIAN risk score
Gabriel, R., Muñiz, J., Vega, S., Moral, I., Pérez-Castro, T. R., Salvanés, F. R., Suárez, C., Novella, B., & Brotons, C. (2021) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2021.05.003 · Cited by 2
Ganjali, S., Lotfaliany, M., Tonkin, A. M., Nelson, M. R., Reid, C. M., McNeil, J. J., Wolfe, R. S., Chowdhury, E., Woods, R. L., Berk, M., et al. (2025) · Heart · doi:10.1136/heartjnl-2025-325665 · Cited by 2
Physical functioning and mortality in very old patients on dialysis
Torino, C., Mattace-Raso, F. U. S., van Saase, J. L. C. M., Panuccio, V. A., Tripepi, R., Vilasi, A. D., Postorino, M., Tripepi, G. L., Mallamaci, F., & Zoccali, C. (2019) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2019.103918 · Cited by 2
Cardona, J., Rodilla, E., & Pascual, J. M. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)12006-3 · Cited by 2
Sisa, I. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.07.037 · Cited by 2
Dimberg, L., Eriksson, B. G., & Enqvist, P. (2020) · The Egyptian Heart Journal · doi:10.1186/s43044-020-00114-9 · Cited by 2
Weak Prediction Power of the Framingham Risk Score for Coronary Artery Disease in Nonagenarians
Yayan, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113044 · Cited by 2
Atherosclerosis plaque area reduction: working hypothesis to prevent cardiovascular event
Pérez, H. A., Allende, G. A. F., Ajayi, E. I. O., Porta, D. J., & Garcia, N. H. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-018-2868-1 · Cited by 2
Selective Indicators for Optical Determination of Disease Biomarkers
Hakuna, L. (2000) · doi:10.15760/etd.2052 · Cited by 2
Improving Risk Stratification for Heart Failure
Daly, M. G., FRAMPTON, C. M. A., & Troughton, R. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.060 · Cited by 2
Pinto, C. J. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-14082018-093502 · Cited by 2
Mawani, M., McNally, B., Knight, J., Shen, Y., & Ebell, M. H. (2025) · medRxiv · doi:10.1101/2025.08.04.25332995 · Cited by 2
Plasma homocysteine and macular thickness in older adults—the Rugao Longevity and Aging Study
Zhang, H., Shen, H., Gong, W., Sun, X., Jiang, X., Wang, J., Li, J., Xu, X., Luo, D., & Wang, X. (2021) · Eye · doi:10.1038/s41433-021-01549-3 · Cited by 1
Cardiovascular risk factors and all-cause mortality in older age (15-year cohort study)
Malyutina, S. K., Симонова, Г. И., Rymar, O. D., Викторовна, М. Е., Shapkina, M., Avdeeva, E. M., Mustafina, S. V., & Вахтанговна, Д. Д. (2024) · Ateroscleroz · doi:10.52727/2078-256x-2024-20-3-229-245 · Cited by 1
Yang, L., Lu, F., Wang, Q., Huang, Q., Ling, S., Xu, N., Jiang, H., Fang, J., Liu, Y., Wang, L., et al. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06548-7 · Cited by 1
Gao, J., Zhang, N., Aximu, A., Xin, N., Wang, Z., & Yan, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-26729-z · Cited by 2
Opsporing en behandeling van hypertensie bij 80-plussers
Koopman, H. (2010) · Huisarts en Wetenschap · doi:10.1007/s12445-010-0033-4 · Cited by 1
New Hypotheses and Viewpoints for Atherosclerosis in 2013
Erzengin, F. (2014) · General Medicine Open Access · doi:10.4172/2327-5146.1000130 · Cited by 1
Homocysteine – what does it mean and have we been led astray?
Young, I. S., & Woodside, J. V. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02297.x · Cited by 1
Hypertension therapy in the oldest patients
Beckett, N. S., & Noimark, D. J. (2009) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0038-3 · Cited by 1
Khudadah, K., Ali, H., Booz, O., Moussa, M., Alabbasi, A., & Al-Adsani, R. (2011) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mejfm.2011.98077 · Cited by 1
Laks, R., Araújo, L. M. Q., de Mello, C., Filho, A., & Cendoroglo, M. S. (2011) · Cited by 1
Ferrari, M. W. (2019) · Geriatrie up2date · doi:10.1055/a-0917-4723 · Cited by 1
Chen, L., Wang, X., Lin, T.-Z., Xiang, H., Liu, H., Xu, S., Yue, J., & Wu, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-74185-y · Cited by 1
Ghanbari, Y., Munshi, M. U. A., & Nagaraju, K. (2016) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.07546 · Cited by 1
Progress in the risk assessment of hydroxychloroquine in frail elderly people
Castagna, A., Ruotolo, G., & Manzo, C. (2020) · Aging Medicine · doi:10.1002/agm2.12140
Wennberg, P. (2009) · DiVA at Umeå University (Umeå University) · Cited by 1
Wells, S. (2010) · Journal of Primary Health Care · doi:10.1071/hc10330 · Cited by 1
Mangin, D. (2010) · Journal of Primary Health Care · doi:10.1071/hc10333 · Cited by 1
Abdelhafiz, A. H. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch7 · Cited by 1
Data-driven modeling and learning approach to solving ICU risk prediction and survival analysis
Yin, Y. (2022) · Digital Repository Service (Northeastern University) · doi:10.17760/d20474701 · Cited by 1
Pathogenesis, prevention and treatment of peripheral artery disease
Brodziak, A. (2014) · Annales Academiae Medicae Silesiensis
van Dijk, S. (2015)
Zairagi, A. (2012) · InTech eBooks · doi:10.5772/39018
Coronary heart disease in the Netherlands : incidence, etiology and risk prediction
Merry, A. H. H. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20101210am
Carrubba, C. J., Blaha, M. J., Nasir, K., & DeFilippis, A. P. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0419-0
Metadata
- Authors
- de Ruijter, W., Westendorp, R. G. J., Assendelft, W. J. J., den Elzen, W. P. J., de Craen, A. J. M., le Cessie, S., & Gussekloo, J.
- Affiliations
- Leiden University Medical Center (NL)
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-01-08
- Volume
- 338
- Issue
- jan08 2
- Pages
- a3083-a3083
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC2615548
- OpenAlex
- W2107794933
- Cited by
- 339
- References
- 87
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 8 · 2023: 13 · 2022: 6 · 2021: 18 · 2020: 20 · 2019: 14 · 2018: 14 · 2017: 25 · 2016: 22 · 2015: 24 · 2014: 34 · 2013: 24 · 2012: 30
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- cardiovascular mortality, oldest old, Framingham risk score, cardiovascular risk factors, homocysteine, biomarkers, C-reactive protein, interleukin-6, folic acid, left ventricular hypertrophy, risk prediction, Leiden 85-plus Study
- MeSH terms
- Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Male, Netherlands, Risk Factors, Cohort Studies, Biomarkers, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review